stella
beta
A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases — Stella
Recruiting
Back to Multiple Sclerosis (MS) trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(3 sites)
China
The Affiliated Hospital of Fujian Medical University, Fuzhou
The First Affiliated Hospital of SOOCHOW University, Suzhou
Union Hospital Tongji Medical College HUAZHONG University of Science and Technology, Wuhan
View full record on ClinicalTrials.gov